Health Economic Evaluation of a Contemplementary Biomarker for Hypothetical Prostate Cancer Screening in Germany
Meier F, Niederländer C, Djanatliev A, Gantner-Bär M, Höllthaler J, Voigt W, Schöffski O, Kolominsky-Rabas P, Emmert M (2013)
Publication Language: English
Publication Type: Journal article, Original article
Publication year: 2013
Journal
Publisher: Wiley-Blackwell: No OnlineOpen / Elsevier
Book Volume: 16
Pages Range: A406
Journal Issue: 7
DOI: 10.1016/j.jval.2013.08.480
Abstract
Prostate cancer (PCA) is the most common cancer in men worldwide. However, there is disagreement about the benefits of existing screening programs. This is mainly due to low specificity of currently utilized biomarkers. This can lead to both inappropriate medical treatment and increasing costs of care. For the future, many biotechnological developments are promising, but not all will be affordable for routine screening. The question is how much a complementary biomarker to prostate-specific antigen (PSA)-test may cost which would be applied to avoid false-positive results.
Authors with CRIS profile
Florian Meier
Lehrstuhl für Betriebswirtschaftslehre, insbesondere Gesundheitsmanagement
Charlotte Niederländer
Interdisziplinäres Zentrum für Public Health
Anatoli Djanatliev
Computer Science 7 (Computer Networks and Communication Systems)
Marion Gantner-Bär
Lehrstuhl für Medizinische Informatik
Oliver Schöffski
Lehrstuhl für Betriebswirtschaftslehre, insbesondere Gesundheitsmanagement
Peter Kolominsky-Rabas
Medizinische Fakultät
Martin Emmert
Lehrstuhl für Betriebswirtschaftslehre, insbesondere Gesundheitsmanagement
Involved external institutions
Germany (DE)How to cite
APA:
Meier, F., Niederländer, C., Djanatliev, A., Gantner-Bär, M., Höllthaler, J., Voigt, W.,... Emmert, M. (2013). Health Economic Evaluation of a Contemplementary Biomarker for Hypothetical Prostate Cancer Screening in Germany. Value in Health, 16(7), A406. https://doi.org/10.1016/j.jval.2013.08.480
MLA:
Meier, Florian, et al. "Health Economic Evaluation of a Contemplementary Biomarker for Hypothetical Prostate Cancer Screening in Germany." Value in Health 16.7 (2013): A406.
BibTeX: Download